Other substances

Fidaxomicin

A macrolide antibiotic.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Fidaxomicin on PubChem

Marketed as

DIFICID

 

Structure image - Fidaxomicin

CC[C@H]1/C=C(/[C@H](C/C=C/C=C(/C(=O)O[C@@H](C/C=C(/C=C(/[C@@H]1O[C@H]2[C@H]([C@H]([C@@H](C(O2)(C)C)OC(=O)C(C)C)O)O)\C)\C)[C@@H](C)O)\CO[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)OC(=O)C4=C(C(=C(C(=C4O)Cl)O)Cl)CC)O)OC)O)\C

Supporting references

Link Tested on Impact factor Notes Publication date
Prediction of potential inhibitors for RNA-dependent RNA polymerase of SARS-CoV-2 using comprehensive drug repurposing and molecular docking approach
RdRpol Small molecule In silico 		in silico 5.16

Predicted to bind the SARS-CoV-2 RNA-dependent RNA polymerase.

 Sep/17/2020
Export (.csv)